A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa March 20, 2025 https://clinicaltrials.gov/study/NCT06028230
